aTyr Pharma, Inc.(ATYR) - 2024 Q4 - Earnings Call Transcript

aTyr Pharma (ATYR) Q4 2024 Earnings Call March 13, 2025 05:00 PM ET Company Participants Ashlee Dunston - Director of Investor Relations & Corporate CommunicationsSanjay Shukla - President & CEOLeslie Nangle - EVP, ResearchJill Broadfoot - CFOPrakhar Agrawal - Managing DirectorLiang Cheng - Senior Research AssociateDev Prasad - SVP & Equity Research Conference Call Participants Derek Archila - Managing Director, Biotechnology Equity Research AnalystYasmeen Rahimi - Sr. Research AnalystFaisal Khurshid - Seni ...